<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>Barclays Lifts PT on UnitedHealth Group (UNH) Stock — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Barclays Lifts PT on UnitedHealth Group (UNH) Stock</h2>
    <div class="badge">2025-09-08T14:29:28+00:00</div>
    <ul>
      <li>Its cash flows from operations came in at $7.2 billion in Q2 2025, or 2.0 times net income.</li>
<li>For FY 2025, UnitedHealth Group Incorporated (NYSE:UNH) expects revenue in the range of $445.5 billion – $448.0 billion.</li>
<li>UnitedHealth Group Incorporated (NYSE:UNH)’s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion, thanks to the growth within UnitedHealthcare and Optum.</li>
<li>Janus Henderson Investors, an investment management company, released its Q2 2025 investor letter.</li>
<li>The firm adjusted its estimates and targets in the managed care and healthcare facility group after the volatile Q2 2025 earnings season.</li>
<li>On September 3, Barclays analyst Andrew Mok lifted the price target on the company’s stock to $352 from $337, while keeping an “Overweight” rating, as reported by The Fly.</li>
<li>From here, Barclays expects several potential catalysts, such as September budget deals, final pricing for Medicare Advantage and Affordable Care Act plans as well as Medicare Advantage star ratings for the 2027 plans.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=Barclays Lifts PT on UnitedHealth Group (UNH) Stock\n• Its cash flows from operations came in at $7.2 billion in Q2 2025, or 2.0 times net income.\n• For FY 2025, UnitedHealth Group Incorporated (NYSE:UNH) expects revenue in the range of $445.5 billion – $448.0 billion.\n• UnitedHealth Group Incorporated (NYSE:UNH)’s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion, thanks to the growth within UnitedHealthcare and Optum.\n• Janus Henderson Investors, an investment management company, released its Q2 2025 investor letter.\n• The firm adjusted its estimates and targets in the managed care and healthcare facility group after the volatile Q2 2025 earnings season.\n• On September 3, Barclays analyst Andrew Mok lifted the price target on the company’s stock to $352 from $337, while keeping an “Overweight” rating, as reported by The Fly.\n• From here, Barclays expects several potential catalysts, such as September budget deals, final pricing for Medicare Advantage and Affordable Care Act plans as well as Medicare Advantage star ratings for the 2027 plans." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/news/barclays-lifts-pt-unitedhealth-group-142928784.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>